Iambic Therapeutics, Inc. (IAM)

Iambic Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Iambic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.02	-0.03	-0.06
Debt / EBITDA Ratio	-0.05	-0.07	-0.12
Debt / FCF Ratio	-0.07	-0.09	-0.18
Net Debt / Equity Ratio	0.87	0.94	1.21
Net Debt / EBITDA Ratio	2.05	2.16	2.56
Net Debt / FCF Ratio	2.97	2.91	3.95
Quick Ratio	4.51	6.92	8.41
Return on Equity (ROE)	40.53%	41.43%	42.65%
Return on Assets (ROA)	-	-39.63%	-30.74%
Return on Invested Capital (ROIC)	-	-53.55%	-38.80%
Return on Capital Employed (ROCE)	206.13%	-48.86%	-38.80%